Early lymph node check is saving lives in melanoma patients

Early lymph node check is saving lives in melanoma patients

19 October 2017

Research presented this week at the 9th World Congress of Melanoma supports the updated guideline recommendation that sentinel lymph node biopsy be performed in more patients newly diagnosed with melanoma, as it has the potential to save lives due to the information the procedure provides.

This biopsy, which looks for cancer cells in the lymph nodes, can identify patients whose melanoma has spread beyond the site on the skin (Stage III melanoma) and who may be suitable to receive the new generation of anti-melanoma drugs.

The recently published Australian Clinical Practice Guidelines for the Diagnosis and Management of Melanoma recommends that “sentinel lymph node biopsy should be considered for all patients with melanoma greater than 1 mm in thickness and for patients with melanoma greater than 0.8 mm with other high risk pathological features to provide optimal staging and prognostic information and to maximise management options for patients who are node positive”.

“We know patients who have melanoma cells present in their draining lymph nodes (Stage III) are up to three times more likely to die from their melanoma than patients where the lymph nodes are clear,” says David Gyorki, a consultant surgeon and melanoma specialist at the Peter MacCallum Cancer Centre.

“For some time, we’ve known that sentinel lymph node biopsy is an excellent way to identify those patients who have a higher risk of having their disease progress, and with the new drugs we have gained the tools to respond and to reduce this risk.

“On the horizon, we will have access to effective, well tolerated drug therapies that can reduce the risk of relapse and, using sentinel lymph node biopsy to identify appropriate patients, the data indicate that this strategy is saving lives.”

For most patients diagnosed with melanoma, their disease is localised and effectively treated with surgery; however, some patients’ disease will progress. Of the 14,000 Australians diagnosed with melanoma each year, almost 15% will die from their disease.

Findings from recent clinical trials have demonstrated a major improvement in survival for patients with Stage III melanoma using drug therapy after surgery with the aim to prevent the melanoma from appearing in distant organs (Stage IV disease).

In one such clinical trial, known as COMBI-AD, patients who received a combination of targeted therapies (dabrafenib and trametinib) decreased the chance of their melanoma progressing by 53% compared to the current standard therapy of ‘watch and wait’.

“We encourage clinicians to inform their patients about sentinel lymph node biopsy so that patients can properly understand their risk of recurrence and death from melanoma, and therefore discuss the option of further drug therapy” says Professor Georgina Long, Medical Oncologist and Co-Medical Director of Melanoma Institute Australia.

The 9th World Congress of Melanoma is underway in Brisbane, October 18 – 21.

Congratulations Dr Hansol Lee
22 Dec 2021

Congratulations Dr Hansol Lee

Promising young MIA researcher conferred with University of Sydney PhD.

Tags: melanoma
MIA joins Sydney Health Partners
14 Dec 2021

MIA joins Sydney Health Partners

Sydney Health Partners' goal is to ensure world class research is successfully implemented & scaled-up to benefit patients & wider society.

Tags: melanoma
Olympians join forces for melanoma warning
13 Dec 2021

Olympians join forces for melanoma warning

Jana Pittman and Melinda Gainsford-Taylor urge Australians to be sun-safe and check their skin as they join the Game On Mole campaign in support of their much-loved coach

Tags: melanoma
MIA research wins Cancer Institute of NSW 'Wildfire Highly Cited Publication'
07 Dec 2021

MIA research wins Cancer Institute of NSW 'Wildfire Highly Cited Publication'

Cited an incredible 427 times around the world, showing its vital role in improving outcomes for people with advanced melanoma.

Tags: melanoma
Prof Richard Scolyer receives University of Tasmania Distinguished Alumni Award
06 Dec 2021

Prof Richard Scolyer receives University of Tasmania Distinguished Alumni Award

Honouring the exceptional impact of his work on communities around the world.

Tags: melanoma
MIA's Co-Medical Directors receive University of Sydney's Vice-Chancellor's Award for Outstanding Research
03 Dec 2021

MIA's Co-Medical Directors receive University of Sydney's Vice-Chancellor's Award for Outstanding Research

Awarded for their life-saving discoveries transforming melanoma patient care.

Tags: melanoma
Aussies urged to mark start of summer by checking their skin
01 Dec 2021

Aussies urged to mark start of summer by checking their skin

National day of action called amidst fears COVID lockdowns have deterred patients from seeking potentially life-saving medical treatment

Tags: melanoma
Prof Georgina Long AO awarded the 2021 Ramaciotti Medal for Excellence in Biomedical Research
24 Nov 2021

Prof Georgina Long AO awarded the 2021 Ramaciotti Medal for Excellence in Biomedical Research

Recognising her pioneering work in immunotherapy in melanoma, transforming the care of patients worldwide.

Tags: melanoma
AMC2021 conference wrap-up
23 Nov 2021

AMC2021 conference wrap-up

Clinicians and researchers from across Australia and beyond united online, bringing the AMC2021 conference theme of Promising Futures to life.

Tags: melanoma
Journalist and news reader Peter Overton our new National Ambassador
23 Nov 2021

Journalist and news reader Peter Overton our new National Ambassador

Melanoma Institute Australia is proud to announce that the Nine Network’s Peter Overton AM has joined us as a National Ambassador.

Tags: melanoma
MIA researchers feature on prestigious Highly Cited Researchers 2021 List
19 Nov 2021

MIA researchers feature on prestigious Highly Cited Researchers 2021 List

MIA is proud to announce that five of our researchers have been named on the Clarivate Annual Highly Cited Researchers™ 2021 list.

Tags: melanoma
New research into importance of skin surveillance to save lives from melanoma
04 Nov 2021

New research into importance of skin surveillance to save lives from melanoma

New research shows routine skin checks by a health professional, coupled with checking your own skin, are vital in saving lives from melanoma.

Tags: melanoma
Game On Mole - saving lives this summer
31 Oct 2021

Game On Mole - saving lives this summer

With new patient figures indicating people may have deferred skin checks during the pandemic our Game On Mole campaign is more important than ever. 

Tags: melanoma
Melanoma March physical events in 2022
22 Oct 2021

Melanoma March physical events in 2022

We are excited to announce a return to our much-loved physical Melanoma March events in March 2022! 

Tags: melanoma
Community Fundraising Wrap Up July-Sept 2021
15 Oct 2021

Community Fundraising Wrap Up July-Sept 2021

Read more about the wonderful MIA community fundraising initiatives held recently.

Tags: melanoma
Australian researchers spearhead paradigm shift in melanoma treatment
20 Sep 2021

Australian researchers spearhead paradigm shift in melanoma treatment

Drug therapy set to become standard treatment in high-risk early stage patients to stop disease spread

Tags: melanoma
Melanoma Bike Bash 2021: What a ride!
20 Sep 2021

Melanoma Bike Bash 2021: What a ride!

Over two fun, yet challenging, days in September an intrepid group of riders and crew successfully completed the annual Melanoma Bike Bash in WA!

Tags: melanoma
Prof Georgina Long AO awarded inaugural Outstanding Female Researcher Medal from AAHMS
16 Sep 2021

Prof Georgina Long AO awarded inaugural Outstanding Female Researcher Medal from AAHMS

Prof Long AO has been recognised by Australian Academy of Health and Medical Sciences for her transformative work advancing melanoma treatments.

Tags: melanoma
MIA researchers awarded $7.2m in NHMRC grants for health research
15 Sep 2021

MIA researchers awarded $7.2m in NHMRC grants for health research

Three MIA researchers at University of Sydney received grants to further their important melanoma research.

Tags: melanoma
Amie St Clair Ball in Wagga postponed for a third time
06 Sep 2021

Amie St Clair Ball in Wagga postponed for a third time

COVID restrictions continue to impact fundraising for melanoma services in Riverina.